United States · FDA National Drug Code directory

SEMAGLUTIDE

Source ingredient · 26 source records

Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.

United States · Source reference 0169-1704_6834044a-22f1-4f35-b846-b3448ee84c16

OZEMPIC

TABLET / Novo Nordisk Pharmaceutical Industries, LP

United States · Source reference 0169-1709_6834044a-22f1-4f35-b846-b3448ee84c16

OZEMPIC

TABLET / Novo Nordisk Pharmaceutical Industries, LP

United States · Source reference 0169-1715_6834044a-22f1-4f35-b846-b3448ee84c16

OZEMPIC

TABLET / Novo Nordisk Pharmaceutical Industries, LP

United States · Source reference 50090-6051_52d28c75-c5a5-4389-abff-8a243ba26d99

OZEMPIC

INJECTION, SOLUTION / A-S Medication Solutions

United States · Source reference 0169-4130_5e1477c5-c1b8-4fc5-af2a-83e5d356a77d

Ozempic

INJECTION, SOLUTION / Novo Nordisk Pharmaceutical Industries, LP

United States · Source reference 0169-4181_5e1477c5-c1b8-4fc5-af2a-83e5d356a77d

Ozempic

INJECTION, SOLUTION / Novo Nordisk Pharmaceutical Industries, LP

United States · Source reference 0169-4772_5e1477c5-c1b8-4fc5-af2a-83e5d356a77d

Ozempic

INJECTION, SOLUTION / Novo Nordisk Pharmaceutical Industries, LP

United States · Source reference 50090-5949_a5c23c93-1c61-4768-b7f2-1e430cd21a8d

Ozempic

INJECTION, SOLUTION / A-S Medication Solutions

United States · Source reference 50090-8027_4b9bdfa7-1075-45cd-baac-66632beb38df

Ozempic

INJECTION, SOLUTION / A-S Medication Solutions

United States · Source reference 0169-4303_6834044a-22f1-4f35-b846-b3448ee84c16

RYBELSUS

TABLET / Novo Nordisk Pharmaceutical Industries, LP

United States · Source reference 0169-4307_6834044a-22f1-4f35-b846-b3448ee84c16

RYBELSUS

TABLET / Novo Nordisk Pharmaceutical Industries, LP

United States · Source reference 0169-4314_6834044a-22f1-4f35-b846-b3448ee84c16

RYBELSUS

TABLET / Novo Nordisk Pharmaceutical Industries, LP

United States · Source reference 0169-4404_f7b108b9-f276-4e32-84e7-e828ba145da5

WEGOVY

TABLET / Novo Nordisk Pharmaceutical Industries, LP

United States · Source reference 0169-4409_f7b108b9-f276-4e32-84e7-e828ba145da5

WEGOVY

TABLET / Novo Nordisk Pharmaceutical Industries, LP

United States · Source reference 0169-4415_f7b108b9-f276-4e32-84e7-e828ba145da5

WEGOVY

TABLET / Novo Nordisk Pharmaceutical Industries, LP

United States · Source reference 0169-4425_f7b108b9-f276-4e32-84e7-e828ba145da5

WEGOVY

TABLET / Novo Nordisk Pharmaceutical Industries, LP

United States · Source reference 0169-4501_f7b108b9-f276-4e32-84e7-e828ba145da5

WEGOVY

INJECTION, SOLUTION / Novo Nordisk Pharmaceutical Industries, LP

United States · Source reference 0169-4505_f7b108b9-f276-4e32-84e7-e828ba145da5

WEGOVY

INJECTION, SOLUTION / Novo Nordisk Pharmaceutical Industries, LP

United States · Source reference 0169-4517_f7b108b9-f276-4e32-84e7-e828ba145da5

WEGOVY

INJECTION, SOLUTION / Novo Nordisk Pharmaceutical Industries, LP

United States · Source reference 0169-4524_f7b108b9-f276-4e32-84e7-e828ba145da5

WEGOVY

INJECTION, SOLUTION / Novo Nordisk Pharmaceutical Industries, LP

United States · Source reference 0169-4525_f7b108b9-f276-4e32-84e7-e828ba145da5

WEGOVY

INJECTION, SOLUTION / Novo Nordisk Pharmaceutical Industries, LP

United States · Source reference 0169-4572_f7b108b9-f276-4e32-84e7-e828ba145da5

WEGOVY

INJECTION, SOLUTION / Novo Nordisk Pharmaceutical Industries, LP

United States · Source reference 0169-4915_f7b108b9-f276-4e32-84e7-e828ba145da5

WEGOVY

INJECTION, SOLUTION / Novo Nordisk Pharmaceutical Industries, LP

United States · Source reference 50090-5824_58b8887c-a572-4a74-ad0b-1049d388e206

WEGOVY

INJECTION, SOLUTION / A-S Medication Solutions

United States · Source reference 61434-067_3c6767c1-075e-4651-e063-6294a90a4d49

semaglutide

INJECTION, SOLUTION / Catalent Indiana, LLC

United States · Source reference 61434-068_3c676f9f-84a1-f136-e063-6394a90a9770

semaglutide

INJECTION, SOLUTION / Catalent Indiana, LLC

Browse ingredients in United States →